Cic edizioni internazionali
Functional Neurology

The usefulness of sLORETA in evaluating the effect of high-dose ARA-C on brain connectivity in patients with acute myeloid leukemia: an exploratory study

Original Article, 195 - 200
doi: 10.11138/FNeur/2017.32.4.195
Tag this article
Abstract
Enhanced HTML Full text PDF
Cytosine arabinoside (Ara-C) is one of the key drugs for treating acute myeloid leukemia (AML). High intravenous doses may produce a number of central nervous system (CNS) toxicities and contribute to modifications in brain functional connectivity. sLORETA is a software used for localizing brain electrical activity and functional connectivity. The aim of this study was to apply sLORETA in the evaluation of possible effects of Ara-C on brain connectivity in patients with AML without CNS involvement.
We studied eight patients with AML; four were administered standard doses of Ara-C while the other four received high doses. sLORETA was computed from computerized EEG data before treatment and after six months of treatment. Three regions of interest, corresponding to specific combinations of Brodmann areas, were defined. In the patients receiving high-dose Ara-C, a statistically significant reduction in functional connectivity was observed in the fronto-parietal network, which literature data suggest is involved in attentional processes.
Our data highlight the possibility of using novel techniques to study potential CNS toxicity of cancer therapy.

Vol. XXXIII (No. 1) 2018 January/March

  1. Mechanical thrombectomy for acute ischemic stroke: the therapeutic window is larger but still “time is brain»
    Zivelonghi C., Tamburin S.
    doi: 10.11138/FNeur/2018.33.1.005
  2. Pharmacological differences and clinical implications of various botulinum toxin preparations: a critical appraisal
    Ferrari A., Manca M., Tugnoli V., Alberto L.
    doi: 10.11138/FNeur/2018.33.1.007
  3. Multicentre registry of brain-injured patients with disorder of consciousness: rationale and preliminary data
    Pascarella A., Fiorenza S., Masotta O., Tibollo V., Vella D., Nardone A. M., Rossi M., Volanti P., Madonia F., Castronovo G., De Cicco D., Guarnaschelli C., Achilli M.P., Chiapparino C., Angelillo M.T., Tommasi M.A., Pisano F., Grioni G., Vezzadini G., Ferriero G., Salvaderi S., Bellazzi R., Estraneo A.
    doi: 10.11138/FNeur/2018.33.1.019
  4. Apathy in Parkinson’s disease: differences between caregiver’s report and self-evaluation
    Valentino V., Iavarone A., Amboni M., Moschiano F., Picillo M., Petretta V., Cicarelli G.
    doi: 10.11138/FNeur/2018.33.1.031
  5. Management of spasticity with onabotulinumtoxinA: practical guidance based on the italian real-life post-stroke spasticity survey
    Sandrini G., Baricich A., Cisari C., Paolucci S., Smania N., Picelli A.
    doi: 10.11138/FNeur/2018.33.1.037
  6. A role for accelerometry in the differential diagnosis of tremor syndromes
    Bove F., Di Lazzaro G., Mulas D., Cocciolillo F., Di Giuda D., Bentivoglio A.R.
    doi: 10.11138/FNeur/2018.33.1.045
  7. Effectiveness of a digital platform for sharing knowledge on headache management: a two-year experience
    Raieli V., Correnti E., Sandullo A., Romano M., Marchese F., Loiacono C., Brighina F.
    doi: 10.11138/FNeur/2018.33.1.051
  8. If you want to understand what it really means to live with cluster headache, imagine... fostering empathy through European patients’ own stories of their experiences
    Rossi P., Little P., De La Torre E.R., Palmaro A.
    doi: 10.11138/FNeur/2018.33.1.057
Last Viewed articles: la lista degli ultimi x visitati.
  1. The usefulness of sLORETA in evaluating the effect of high-dose ARA-C on brain connectivity in patients with acute myeloid leukemia: an exploratory study
    Zarabla A., Ungania S., Cacciatore A., Maialetti A., Petreri G., Mengarelli A., Spadea A., Marchesi F., Renzi D., Gumenyuk S., Strigari L., Maschio M.
    doi: 10.11138/FNeur/2017.32.4.195
credits